Exagen Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, the company reported revenue of $10,587,000 against $9,584,000 a year ago. Loss from operations was $5,567,000 against $5,221,000 a year ago. Net loss was $6,209,000 or $0.48 per basic and diluted share against $5,563,000 or $0.44 per basic and diluted share a year ago.